Cancer Drug for MS Brings Up More Thoughts on Off Label Prescribing
by Wesley J. SmithThe other day, to the consternation of some, I discussed my opposition to “off label” prescribing, meaning when a drug is approved for use to treat one malady, it is prescribed for a different one even though the medication was not specifically tested for that circumstance. To me, off . . . . Continue Reading »